共 50 条
- [1] Low usage of calcium and vitamin D with bisphosphonate therapy in post-menopausal osteoporotic women in France and in SpainOSTEOPOROSIS INTERNATIONAL, 2007, 18 : S150 - S151Quesada, J. M.Mann, B.
- [2] Persistence and compliance with bisphosphonate therapy among post-menopausal osteoporotic womenVALUE IN HEALTH, 2004, 7 (06) : 724 - 724Cramer, JAmonkar, MMHebborn, ASuppapanya, N
- [3] Compliance with bisphosphonate therapy reduces risk of osteoporotic fracture by 25-30% in post-menopausal womenPHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2006, 15 : S294 - S295Penning-van Beest, Fernie J. A.van den Boogaard, Christel H. A.Erkens, Joelle A.Engbersen, Astrid M. T.Herings, Ron M. C.
- [4] Proportion of osteoporotic post-menopausal women at increased risk for upper GI adverse events associated with bisphosphonate therapyPHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2000, 9 (05) : 367 - 370Levine, MAHGrootendorst, P
- [6] Carotid atherosclerosis in post-menopausal and osteoporotic womenJOURNAL OF HYPERTENSION, 2007, 25 : S365 - S365D'Amico, F.
- [7] BONE LOSS IN POST-MENOPAUSAL AND OSTEOPOROTIC WOMENCALCIFIED TISSUE INTERNATIONAL, 1980, 31 (01) : 60 - 60ALOIA, JFCOHN, SHROSS, PZANZI, IVASWANI, AELLIS, K
- [8] Serum pentosidine levels after 3 years of bisphosphonate treatment in post-menopausal osteoporotic womenENDOCRINE RESEARCH, 2015, 40 (03) : 172 - 176Hashidate, HiroyukiKamimura, MikioIkegami, ShotaMukaiyama, KeijiroUchiyama, ShigeharuNakamura, YukioKato, Hiroyuki
- [9] Copper, magnesium, zinc and calcium status in osteopenic and osteoporotic post-menopausal womenCLINICAL CASES IN MINERAL AND BONE METABOLISM, 2015, 12 (01) : 18 - 21Mahdavi-Roshan, MarjanEbrahimi, MehrangizEbrahimi, Aliasgar
- [10] Determinants of non-compliance with bisphosphonate therapy in women with post-menopausal osteoporosisOSTEOPOROSIS INTERNATIONAL, 2006, 17 : S71 - S71van den Boogaard, CH. A.Penning-van Beast, F. J. A.Erkens, J. A.Engbersen, A. M. T.Herings, R. M. C.